Brisbane Broncos prop Corey Jensen’s rugby league career faces significant uncertainty after recent medical examinations revealed persistent blood clots in both of his lungs. Jensen, 32, was diagnosed with multiple pulmonary embolisms following Brisbane’s Round 7 match against the Wests Tigers on April 18, when he experienced shortness of breath, chest pain, and coughing up blood. Subsequent scans showed that one clot had obstructed blood flow to part of his right lung.
Jensen has been undergoing treatment under a multidisciplinary team at Brisbane’s Mater Private Hospital, including specialists in respiratory medicine, cardiology, haematology, and infectious diseases. Since his diagnosis, he has been prescribed Warfarin, a blood-thinning anticoagulant, which carries bleeding risks that currently prevent him from engaging in contact training or playing rugby league. He has, however, been able to continue running and weight training.
The former North Queensland Cowboys player had previously experienced a deep vein thrombosis (DVT) in his calf about a year ago, an event considered unprovoked since it lacked any clear triggering factors such as injury or long travel. Follow-up scans indicate that while the clots have improved, they remain present. Jensen is awaiting further blood tests within the next three weeks to determine whether an underlying autoimmune disorder might be contributing to his recurrent clotting.
Broncos club doctor Matt Hislop indicated that the future of Jensen’s playing career remains uncertain. Depending on the results of the upcoming blood tests, Jensen may require lifelong anticoagulant therapy. If this scenario arises, Warfarin or similar blood thinners could potentially restrict, or in a risk-managed way allow, his participation in contact sport, but there are no guarantees. Dr. Hislop noted the possibility of switching to different blood-thinning medications that might be temporarily paused around contact training and matches to mitigate bleeding risks, but acknowledged this approach is not without danger.
Jensen’s current contract with the Broncos expires at the end of the season, and his long-term professional future depends heavily on the progress of his medical condition. The Broncos will prioritize his health and well-being as they work with the player to determine the most appropriate treatment strategy.
Amid these challenges, Jensen has expressed gratitude for the support he has received from fans, teammates, and medical staff during this difficult period. His case highlights the complexities athletes can face when serious health conditions intersect with the physical demands of professional sports.